enVVeno Medical (NVNO) Preferred Stock Liabilities (2017)

enVVeno Medical (NVNO) recorded quarterly Preferred Stock Liabilities of $1.2 million in Q4 2017.

enVVeno Medical (NVNO) Preferred Stock Liabilities (2017) Analysis & Trends

enVVeno Medical's Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $1.2 million for Q4 2017.

In Q4 2017, Preferred Stock Liabilities changed N/A year-over-year to $1.2 million; the TTM figure through Dec 2017 stood at $1.2 million (changed N/A YoY), while the FY2017 annual figure was $1.2 million, changed N/A from the prior year.
Preferred Stock Liabilities was $1.2 million for Q4 2017 at enVVeno Medical.
In the past five years, Preferred Stock Liabilities ranged from a high of $1.2 million in Q4 2017 to a low of $1.2 million in Q4 2017.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	enVVeno Medical	6.86 Mn	6.86 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2017	1.24 Mn